Amomum xanthioides (Zingiberaceae) is a perennial herb and its seeds, listed in the Japanese Pharmacopoeia as Amomum seed, have been used in folk medicines for the treatment of stomach and digestive disorders. 1 Previous chemical investigations have demonstrated that the essential oil (1 ~ 1.5%) of this plant was rich in monoterpenoids. 2, 3 As a part of our search for new bioactive substances from medicinal plants, 4, 5 we conducted a further chemical investigation of the seeds of A. xanthioides, which led to isolation of an unusual 15,16-bisnorlabdane diterpenoid, named amoxanthin A (1). The structure of 1, including the absolute stereochemistry, was elucidated by spectroscopic methods and CD data analysis.
Amoxanthin ) units. The UV spectrum of 1 showed an absorption maxima at 228 nm, corresponding to an α,β-unsaturated ketone. The 1 H NMR spectrum ( Table 1 ) of 1 displayed signals for three quarternary methyl protons at δ 0.86 (3H, s) and 0.91 (6H, s) and for two exomethylene protons at δ 4.42 (1H, d, J = 1.5 Hz), 4.81 (1H, d, J = 1.5 Hz), suggesting that 1 possesses the bicyclic carbon skeleton of labdane. 6 The 1 H NMR spectra also showed signals for an olefinic bond at δ 6.08 (1H, d, J = 16.0 Hz), 6.88 (1H, dd, J = 16.0, 10.0 Hz), and a quarternary methyl proton at δ 2.28 (3H, s), indicating the presence of a side chain, α,β-unsaturated ketone. The 13 C NMR and DEPT spectra ( Table 1) of 1 showed 18 carbon signals, composed of four methyl, six methylene (one terminal olefinic), four methine (two olefinic), and four quaternary carbons (one ketone, one olefinic). The 13 C NMR data showed resonances for four olefinic carbons at δ 108.8 (C-17), 133.8 (C-12), 146.9 (C-11), and 148.8 (C-8), and a carbonyl carbon at δ 198.3 (C-13), suggesting that 1 is a bicyclic bisnorditerpenoid, due to the remaining degrees of unsaturation and a total of 18 carbon signals.
The bicyclic bisnorditerpene skeleton of 1 was further confirmed by 2D NMR studies. Its 25 +6.6 o / +4.5 o ), 7,8 isolated from Alpinia genus. To establish the absolute structure of 1, compound 2 was prepared via the ozonolysis of 1 (Scheme 1). 8 The absolute stereochemistry of 1 could be determined by application of the octant rule using the Cotton effect of the n → π* band near 290 nm. 8 The CD spectrum of 2 showed a positive Cotton effect at 290 nm (∆ε = +3.32), which indicated 5R, 9S, and 10R of 2 based on reported data. 8 On the basis of above findings, the structure of 1 was established and the absolute configuration of the chiral centers of 1 were assigned as 5R, 9R, and 10R, and named as amoxanthin A.
It is worth noting that bisnorlabdane diterpenoid was rarely found in natural sources. 9, 10 In this paper, we suggest that the C-1 (δ 36.6) and C-7 (δ 40.9) assignments of the bisnorlabdane diterpene, (E)-15,16,-bisnorlabda-8(17),11-diene-13-one, 7, 8 determined by the Itokawa group should be corrected since those of its stereoisomer, amoxanthin A (1) were unequivocally assigned as δ 41.1 (C-1) and δ 36.8 (C-7) by detailed analysis of 2D NMR data in the present study. The cytotoxicity of 1 was evaluated against the A549 (a non small cell lung carcinoma), SK-OV-3 (ovary malignant ascites), SK-MEL-2 (skin melanoma), and HCT15 (colon adenocarcinoma) human tumor cell lines in vitro using the SRB assay. 11 Compound 1 was found to have moderate cytotoxicity against A549, SK-OV-3, SK-MEL-2, and HCT15 cell lines (IC50: 13.9, 15.2, 11.8 and 12.6 µM, respectively).
Experimental Section
General procedures. Optical rotations were measured on a Jasco P-1020 polarimeter in MeOH. IR spectra were recorded on a Bruker IFS-66/S FT-IR spectrometer. UV spectra were recorded using a Schimadzu UV-1601 UV-visible spectrophotometer. CD spectra were measured on a JASCO J-715 spectropolarimeter. FAB and HRFAB mass spectra were obtained on a JEOL JMS700 mass spectrometer. NMR spectra, including Extraction and isolation. The seeds of A. xanthioides (2.5 kg) were extracted at room temperature with 80% MeOH and evaporated under reduced pressure to give a residue (210 g), which was dissolved in water (800 mL) and partitioned with solvent to give n-hexane (18 g), CHCl3 (11 g), and n-BuOH (23 g) soluble portions. The n-hexane soluble fraction (18 g) was subjected to column chromatography (CC) over a silica gel (230 ~ 400 mesh, 500 g, 6 × 90 cm), eluting with a gradient solvent system of n-hexane-EtOAc (10 : 1 and 1 : 1, 2 L of each solvent) to yield seven crude fractions (F1 -F7). F3 (1.3 g) was applied to CC over Sephadex LH-20 (Pharmacia Co.), eluting with a solvent system of CH 2 Cl 2 -MeOH (1 : 1) and purified further by semipreparative HPLC, using n-hexane-EtOAc (10 : 1) over 30 min at a flow rate of 2.0 mL/min (Apollo Silica 5 µ column; Shodex refractive index detector) to yield 1 (5 mg (3.5 mg) in MeOH (5 mL) was bubbled with O3 for 15 minutes at 0 o C. The reaction mixture was stirred for 1 hr at 30 o C with acetic acid (0.25 mL) and zinc powder (10 mg). Then the solvent was evaporated and the product was subjected to HPLC (n-hexane-EtOAc, 5 : 2) to give compound 2 (1.3 mg). Cytotoxicity assay. A sulforhodamine B bioassay (SRB) was used to determine the cytotoxicity of each compound against four cultured human cancer cell lines. 11 The cell lines used were A549 (non small cell lung adenocarcinoma), SK-OV-3 (ovarian cancer cells), SK-MEL-2 (skin melanoma), and HCT15 (colon cancer cells). Doxorubicin (Sigma Chemical Co., ≥ 98%) was used as a positive control.
